These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 2307193
1. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route. Maren TH, Bar-Ilan A, Conroy CW, Brechue WF. Exp Eye Res; 1990 Jan; 50(1):27-36. PubMed ID: 2307193 [Abstract] [Full Text] [Related]
2. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals. Sugrue MF, Gautheron P, Mallorga P, Nolan TE, Graham SL, Schwam H, Shepard KL, Smith RL. Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013 [Abstract] [Full Text] [Related]
6. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals. Sugrue MF, Mallorga P, Schwam H, Baldwin JJ, Ponticello GS. Curr Eye Res; 1990 Jun; 9(6):607-15. PubMed ID: 2117519 [Abstract] [Full Text] [Related]
7. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring? Borras J, Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT. Bioorg Med Chem; 1999 Nov; 7(11):2397-406. PubMed ID: 10632049 [Abstract] [Full Text] [Related]
8. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT. J Med Chem; 1999 Jul 15; 42(14):2641-50. PubMed ID: 10411484 [Abstract] [Full Text] [Related]
9. Carbonic anhydrase inhibitors. Part 71. Synthesis and ocular pharmacology of a new class of water-soluble, topically effective intraocular pressure lowering sulfonamides incorporating picolinoyl moieties. Supuran CT, Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G. Eur J Pharm Sci; 1999 Aug 15; 8(4):317-28. PubMed ID: 10425382 [Abstract] [Full Text] [Related]
10. [Pharmacological profiles of the potent carbonic anhydrase inhibitor dorzolamide hydrochloride, a topical antiglaucoma agent]. Kobayashi M, Naito K. Nihon Yakurigaku Zasshi; 2000 Jun 15; 115(6):323-8. PubMed ID: 10948564 [Abstract] [Full Text] [Related]
11. Clinical pharmacokinetics of dorzolamide. Martens-Lobenhoffer J, Banditt P. Clin Pharmacokinet; 2002 Jun 15; 41(3):197-205. PubMed ID: 11929320 [Abstract] [Full Text] [Related]
12. Ocular hypotensive activity and disposition of the topical carbonic anhydrase inhibitor 6-hydroxy-benzo[b]thiophene-2-sulfonamide, L-650,719, in the rabbit. Bar-Ilan A, Pessah NI, Maren TH. J Ocul Pharmacol; 1989 Jun 15; 5(2):99-110. PubMed ID: 2754300 [Abstract] [Full Text] [Related]
13. [The time required topical carbonic anhydrase inhibitor (MK-507) to take effect on intraocular pressure of normal human eyes]. Nakagami T, Yamazaki Y, Miyamoto S, Sawa M. Nippon Ganka Gakkai Zasshi; 1995 Sep 15; 99(9):1022-5. PubMed ID: 7484502 [Abstract] [Full Text] [Related]
14. [Effect of topical carbonic anhydrase inhibitor (MK-507) on intraocular pressure of normal human eyes]. Yamazaki Y, Miyamoto S, Sawa M. Nippon Ganka Gakkai Zasshi; 1994 Mar 15; 98(3):293-7. PubMed ID: 8154389 [Abstract] [Full Text] [Related]
15. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor. Sharir M, Pierce WM, Chen D, Zimmerman TJ. Exp Eye Res; 1994 Jan 15; 58(1):107-16. PubMed ID: 8157096 [Abstract] [Full Text] [Related]
16. Effect of pH on the ocular distribution of a topical carbonic anhydrase inhibitor. Conroy CW, Maren TH. Exp Eye Res; 1995 Aug 15; 61(2):213-22. PubMed ID: 7556485 [Abstract] [Full Text] [Related]
17. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors. Brechue WF, Maren TH. Invest Ophthalmol Vis Sci; 1993 Jul 15; 34(8):2581-7. PubMed ID: 8325759 [Abstract] [Full Text] [Related]
18. [A new topical carbonic anhydrase inhibitor (MK-927). Tolerance comparison with betaxolol in healthy probands]. Feicht B, Hofmann HM, Lippa E, Brunner-Ferber F, von Denffer H, Merté HJ. Klin Monbl Augenheilkd; 1990 Sep 15; 197(3):254-7. PubMed ID: 2255169 [Abstract] [Full Text] [Related]
19. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. Sugrue MF. J Ocul Pharmacol Ther; 1996 Sep 15; 12(3):363-76. PubMed ID: 8875343 [Abstract] [Full Text] [Related]
20. Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit. Fanous MM, Challa P, Maren TH. J Ocul Pharmacol Ther; 1999 Feb 15; 15(1):51-7. PubMed ID: 10048347 [Abstract] [Full Text] [Related] Page: [Next] [New Search]